<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">24596620</PMID><DateCompleted><Year>2014</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1976-9148</ISSN><JournalIssue CitedMedium="Print"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2014</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Biomolecules &amp; therapeutics</Title><ISOAbbreviation>Biomol Ther (Seoul)</ISOAbbreviation></Journal><ArticleTitle>Antiviral Activity of Hederasaponin B from Hedera helix against Enterovirus 71 Subgenotypes C3 and C4a.</ArticleTitle><Pagination><StartPage>41</StartPage><EndPage>46</EndPage><MedlinePgn>41-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4062/biomolther.2013.108</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is the predominant cause of hand, foot and mouth disease (HFMD). The antiviral activity of hederasaponin B from Hedera helix against EV71 subgenotypes C3 and C4a was evaluated in vero cells. In the current study, the antiviral activity of hederasaponin B against EV71 C3 and C4a was determined by cytopathic effect (CPE) reduction method and western blot assay. Our results demonstrated that hederasaponin B and 30% ethanol extract of Hedera helix containing hederasaponin B showed significant antiviral activity against EV71 subgenotypes C3 and C4a by reducing the formation of a visible CPE. Hederasaponin B also inhibited the viral VP2 protein expression, suggesting the inhibition of viral capsid protein synthesis.These results suggest that hederasaponin B and Hedera helix extract containing hederasaponin B can be novel drug candidates with broad-spectrum antiviral activity against various subgenotypes of EV71.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Jaehyoung</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Vaccine Research, Center for Infectious Diseases, National Institute of Health, Korea Centers for Diseases Control and Prevention, Osong 363-951 ; College of Pharmacy, Kangwon National University, Chuncheon 200-701.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeo</LastName><ForeName>Sang-Gu</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Division of Vaccine Research, Center for Infectious Diseases, National Institute of Health, Korea Centers for Diseases Control and Prevention, Osong 363-951 ; Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University, Seoul 151-742.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Eun-Hye</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Kangwon National University, Chuncheon 200-701.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Bo-Ra</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Kangwon National University, Chuncheon 200-701.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jin-Won</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Division of Vaccine Research, Center for Infectious Diseases, National Institute of Health, Korea Centers for Diseases Control and Prevention, Osong 363-951.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jeonghoon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ahn-Gook Pharmaceutical Co., LTD, Seoul 150-953, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeong</LastName><ForeName>Hyeongun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Ahn-Gook Pharmaceutical Co., LTD, Seoul 150-953, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Yongsoo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Kangwon National University, Chuncheon 200-701.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyunpyo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Kangwon National University, Chuncheon 200-701.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sangwon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Vaccine Research, Center for Infectious Diseases, National Institute of Health, Korea Centers for Diseases Control and Prevention, Osong 363-951.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jae-Hak</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University, Seoul 151-742.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Hyun-Jeong</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Kangwon National University, Chuncheon 200-701.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Biomol Ther (Seoul)</MedlineTA><NlmUniqueID>101472832</NlmUniqueID><ISSNLinking>1976-9148</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antiviral activity</Keyword><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">Hand foot and mouth disease</Keyword><Keyword MajorTopicYN="N">Hedera helix</Keyword><Keyword MajorTopicYN="N">Hederasaponin B</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24596620</ArticleId><ArticleId IdType="pmc">PMC3936428</ArticleId><ArticleId IdType="doi">10.4062/biomolther.2013.108</ArticleId><ArticleId IdType="pii">41-46_bt22-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown BA, Oberste MS, Alexander JP, Jr, Kennett ML, Pallansch MA. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol. 1999;73:9969&#x2013;9975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC113047</ArticleId><ArticleId IdType="pubmed">10559310</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardosa MJ, Perera D, Brown BA, Cheon D, Chan HM, Chan KP, Cho H, McMinn P. Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis. 2003;9:461&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2957976</ArticleId><ArticleId IdType="pubmed">12702227</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan YF, Sam IC, AbuBakar S. Phylogenetic designation of enterovirus 71 genotypes and subgenotypes using complete genome sequences. Infect Genet Evol. 2010;10:404&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pubmed">19465162</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Lin TY, Huang YC, Tsao KC, Shih SR, Kuo ML, Ning HC, Chung PW, Kang CM. Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. Pediatr Infect Dis J. 1999;18:1092&#x2013;1096.</Citation><ArticleIdList><ArticleId IdType="pubmed">10608631</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi HJ, Kim JH, Lee CH, Ahn YJ, Song JH, Baek SH, Kwon DH. Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus. Antiviral Res. 2009;81:77&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7114206</ArticleId><ArticleId IdType="pubmed">18992773</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov M, Voroshilova M, Shindarov L, Lavrova I, Gracheva L, Koroleva G, Vasilenko S, Brodvarova I, Nikolova M, Gyurova S, Gacheva M, Mitov G, Ninov N, Tsylka E, Robinson I, Frolova M, Bashkirtsev V, Martiyanova L, Rodin V. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol. 1979;60:329&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">228639</ArticleId></ArticleIdList></Reference><Reference><Citation>De Palma AM, Vliegen I, De Clercq E, Neyts J. Selective inhibitors of picornavirus replication. Med Res Rev. 2008;28:823&#x2013;884.</Citation><ArticleIdList><ArticleId IdType="pubmed">18381747</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischer R, Laessig K. Safety and efficacy evaluation of pleconaril for treatment of the common cold. Clin Infect Dis. 2003;37:1722.</Citation><ArticleIdList><ArticleId IdType="pubmed">14689362</ArticleId></ArticleIdList></Reference><Reference><Citation>Gepdiremen A, Mshvildadze V, Suleyman H, Elias R. Acute anti-inflammatory activity of four saponins isolated from ivy: alpha-hederin, hederasaponin-C, hederacolchiside-E and hederacolchiside-F in carrageenan-induced rat paw edema. Phytomedicine. 2005;12:440&#x2013;444.</Citation><ArticleIdList><ArticleId IdType="pubmed">16008120</ArticleId></ArticleIdList></Reference><Reference><Citation>Graci JD, Cameron CE. Mechanisms of action of ribavirin against distinct viruses. Rev Med Virol. 2006;16:37&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169142</ArticleId><ArticleId IdType="pubmed">16287208</ArticleId></ArticleIdList></Reference><Reference><Citation>Han LT, Fang Y, Li MM, Yang HB, Huang F. The antitumor effects of triterpenoid saponins from the anemone flaccida and the underlying mechanism. Evid Based Complement Alternat Med. 2013;2013:517931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3804048</ArticleId><ArticleId IdType="pubmed">24191167</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang YP, Lin TL, Hsu LC, Chen YJ, Tseng YH, Hsu CC, Fan WB, Yang JY, Chang FY, Wu HS. Genetic diversity and C2-like subgenogroup strains of enterovirus 71, Taiwan, 2008. Virol J. 2010;7:277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2975644</ArticleId><ArticleId IdType="pubmed">20959020</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyypia T, Hovi T, Knowles NJ, Stanway G. Classification of enteroviruses based on molecular and biological properties. J Gen Virol. 1997;78:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">9010279</ArticleId></ArticleIdList></Reference><Reference><Citation>Laine P, Savolainen C, Blomqvist S, Hovi T. Phylogenetic analysis of human rhinovirus capsid protein VP1 and 2A protease coding sequences confirms shared genus-like relationships with human enteroviruses. J Gen Virol. 2005;86:697&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pubmed">15722530</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin ZX, Hoult JR, Raman A. Sulphorhodamine B assay for measuring proliferation of a pigmented melanocyte cell line and its application to the evaluation of crude drugs used in the treatment of vitiligo. J Ethnopharmacol. 1999;66:141&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">10433470</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 2002;26:91&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Park KS, Choi YJ, Park JS. Enterovirus infection in Korean children and anti-enteroviral potential candidate agents. Korean J Pediatr. 2012;55:359&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3488610</ArticleId><ArticleId IdType="pubmed">23133481</ArticleId></ArticleIdList></Reference><Reference><Citation>Pevear DC, Tull TM, Seipel ME, Groarke JM. Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother. 1999;43:2109&#x2013;2115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC89431</ArticleId><ArticleId IdType="pubmed">10471549</ArticleId></ArticleIdList></Reference><Reference><Citation>Poyry T, Kinnunen L, Hyypia T, Brown B, Horsnell C, Hovi T, Stanway G. Genetic and phylogenetic clustering of enteroviruses. J Gen Virol. 1996;77:1699&#x2013;1717.</Citation><ArticleIdList><ArticleId IdType="pubmed">8760417</ArticleId></ArticleIdList></Reference><Reference><Citation>Sieben A, Prenner L, Sorkalla T, Wolf A, Jakobs D, Runkel F, Haberlein H. Alpha-hederin, but not hederacoside C and hederagenin from Hedera helix, affects the binding behavior, dynamics, and regulation of beta 2-adrenergic receptors. Biochemistry. 2009;48:3477&#x2013;3482.</Citation><ArticleIdList><ArticleId IdType="pubmed">19278262</ArticleId></ArticleIdList></Reference><Reference><Citation>Simoes CM, Amoros M, Girre L. Mechanism of antiviral activity of triterpenoid saponins. Pytother Res. 1999;13:323&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pubmed">10404540</ArticleId></ArticleIdList></Reference><Reference><Citation>Suleyman H, Mshvildadze V, Gepdiremen A, Elias R. Acute and chronic antiinflammatory profile of the ivy plant, Hedera helix, in rats. Phytomedicine. 2003;10:370&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pubmed">12834000</ArticleId></ArticleIdList></Reference><Reference><Citation>Trute A, Gross J, Mutschler E, Nahrstedt A. In vitro antispasmodic compounds of the dry extract obtained from. Hedera helix Planta Med. 1997;63:125&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">9140224</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Huang KJ, Wu JM, Wang JR, Yu CK, Su IJ, Liu CC. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis. 2003;188:564&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pubmed">12898444</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Wang J, Guo W, Wang H, Zhu S, Wang D, Bai R, Li X, Yan D, Wang H, Zhang Y, Zhu Z, Tan X, An H, Xu A, Xu W. Emergence and transmission pathways of rapidly evolving evolutionary branch C4a strains of human enterovirus 71 in the Central Plain of China. PloS One. 2011;6:e27895.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220707</ArticleId><ArticleId IdType="pubmed">22125635</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>